(R)-endo-3-(4-chlorophenyl)-2-(2-(4-methoxyphenyl)acetamido)-N-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)propanamide

ID: ALA1774020

PubChem CID: 54587188

Max Phase: Preclinical

Molecular Formula: C26H32ClN3O3

Molecular Weight: 470.01

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(CC(=O)N[C@H](Cc2ccc(Cl)cc2)C(=O)N[C@H]2C[C@H]3CC[C@@H](C2)N3C)cc1

Standard InChI:  InChI=1S/C26H32ClN3O3/c1-30-21-9-10-22(30)16-20(15-21)28-26(32)24(13-17-3-7-19(27)8-4-17)29-25(31)14-18-5-11-23(33-2)12-6-18/h3-8,11-12,20-22,24H,9-10,13-16H2,1-2H3,(H,28,32)(H,29,31)/t20-,21+,22-,24-/m1/s1

Standard InChI Key:  HQFLWOURXMVMMC-JTOYRKQZSA-N

Molfile:  

     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   -0.6674  -15.8913    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0477  -16.3027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7615  -15.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7603  -15.0640    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4767  -16.3004    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1905  -15.8868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9820  -15.3428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5295  -14.6210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7268  -14.5410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6913  -16.1222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9055  -16.3672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1351  -15.0967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9375  -15.3333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1458  -14.6250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3812  -16.3049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0963  -15.8935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3799  -17.1299    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8102  -16.3071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5211  -15.8923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2344  -16.3052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2336  -17.1311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5134  -17.5423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8030  -17.1270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4930  -13.7498    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    4.2577  -16.7221    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0490  -17.1277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7641  -17.5390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7610  -18.3636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4753  -18.7749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1901  -18.3612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1861  -17.5319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4713  -17.1244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9058  -18.7716    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -4.9468  -17.5456    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6625  -17.1352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 15 17  2  0
  6  5  1  6
 16 18  1  0
  7  8  1  0
 18 19  2  0
  8  9  1  0
 19 20  1  0
  7 10  1  0
 20 21  2  0
 11  6  1  0
 21 22  1  0
  6 12  1  0
 22 23  2  0
 23 18  1  0
 12  9  1  0
  9 24  1  1
 10 11  1  0
 10 25  1  1
  1  2  1  0
  2 26  1  1
  9 13  1  0
 26 27  1  0
 10 13  1  0
 27 28  2  0
  3  4  2  0
 28 29  1  0
 13 14  1  0
 29 30  2  0
 30 31  1  0
  1 15  1  0
 31 32  2  0
 32 27  1  0
  3  5  1  0
 30 33  1  0
 15 16  1  0
 21 34  1  0
  2  3  1  0
 34 35  1  0
M  END

Associated Targets(Human)

AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Avpr1a Vasopressin V1a receptor (612 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 470.01Molecular Weight (Monoisotopic): 469.2132AlogP: 3.36#Rotatable Bonds: 8
Polar Surface Area: 70.67Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.48CX Basic pKa: 9.25CX LogP: 3.15CX LogD: 1.30
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.62Np Likeness Score: -0.65

References

1. Napier S, Wishart G, Arbuckle W, Baker J, Barn D, Bingham M, Brown A, Byford A, Claxton C, Craighead M, Buchanan K, Fielding L, Gibson L, Goodwin R, Goutcher S, Irving N, MacSweeney C, Milne R, Mort C, Presland J, Sloan H, Thomson F, Turnbull Z, Young T..  (2011)  The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonists.,  21  (10): [PMID:21458261] [10.1016/j.bmcl.2011.02.096]

Source